abstract |
The present invention corresponds to the field of cancer and is related to predicting cancer detection, diagnosis,monitoring and prediction of response to treatment, in particular platelet derived-endothelial cell growth factor (PD-ECGF) levels for their use as a potential value in monitoring disease evolution and predicting response to anti-angiogenic treatment. |